People: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

92.05CHF
11:12am EST
Price Change (% chg)

CHF3.10 (+3.49%)
Prev Close
CHF88.95
Open
CHF90.95
Day's High
CHF92.30
Day's Low
CHF90.30
Volume
6,518,905
Avg. Vol
5,313,615
52-wk High
CHF94.25
52-wk Low
CHF68.10

Search Stocks

Vanni, Enrico 

Brief Biography

Dr. Enrico Vanni, Ph.D., has been Member of the Board of Directors at Novartis AG since 2011. He qualifies as an Independent Non-Executive Director. He is Member of the Audit and Compliance Committee, and Chairman of the Compensation Committee at the Company. He began his career as a research engineer at International Business Machines Corp. in California, and joined McKinsey & Company in Zurich, Switzerland, in 1980. He managed the Geneva office for McKinsey from 1988 to 2004, and consulted for companies in the pharmaceutical, consumer and finance sectors. He led its European pharmaceutical practice and served as Member of the Partner review committee of the firm prior to his retirement in 2007. Since his retirement as Director of McKinsey & Company in 2007, Dr. Vanni has been an independent consultant. He is currently Member of several Boards of Directors in industries from healthcare to private banking, for nonlisted companies including Eclosion2, Denzler & Partners SA and Banque Privee BCP (Suisse) SA. Dr. Vanni holds an engineering degree in chemistry from Ecole polytechnique federale de Lausanne (the Federal Polytechnic School of Lausanne), Switzerland, a Ph.D. in chemistry from Universite de Lausanne, as well as a Master of Business Administration from INSEAD in Fontainebleau, France.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
710,022 -- 41,010 751,032

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joerg Reinhardt

1,900,810

Joseph Jimenez

13,226,300

Ulrich Lehner

1,328,210

Harry Kirsch

2,344,290

Peter Kornicker

--

Felix Ehrat

4,321,510
As Of 30 Dec 2013
Search Stocks